- Home
- LVO vs ATRA Comparison
LVO vs ATRA Comparison
Compare LVO & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LVO
- ATRA
- Stock Information
- Founded
- LVO 2009
- ATRA 2012
- Country
- LVO United States
- ATRA United States
- Employees
- LVO N/A
- ATRA N/A
- Industry
- LVO Restaurants
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LVO Consumer Discretionary
- ATRA Health Care
- Exchange
- LVO Nasdaq
- ATRA Nasdaq
- Market Cap
- LVO 75.7M
- ATRA 65.1M
- IPO Year
- LVO N/A
- ATRA 2014
- Fundamental
- Price
- LVO $1.06
- ATRA $9.81
- Analyst Decision
- LVO Strong Buy
- ATRA Hold
- Analyst Count
- LVO 2
- ATRA 5
- Target Price
- LVO $2.75
- ATRA $26.88
- AVG Volume (30 Days)
- LVO 309.3K
- ATRA 70.9K
- Earning Date
- LVO 02-06-2025
- ATRA 11-12-2024
- Dividend Yield
- LVO N/A
- ATRA N/A
- EPS Growth
- LVO N/A
- ATRA N/A
- EPS
- LVO N/A
- ATRA N/A
- Revenue
- LVO $127,817,000.00
- ATRA $100,439,000.00
- Revenue This Year
- LVO $7.88
- ATRA $1,368.80
- Revenue Next Year
- LVO $6.34
- ATRA N/A
- P/E Ratio
- LVO N/A
- ATRA N/A
- Revenue Growth
- LVO 17.10
- ATRA 2111.34
- 52 Week Low
- LVO $0.56
- ATRA $6.50
- 52 Week High
- LVO $2.15
- ATRA $39.50
- Technical
- Relative Strength Index (RSI)
- LVO 58.14
- ATRA 38.35
- Support Level
- LVO $0.96
- ATRA $10.12
- Resistance Level
- LVO $1.21
- ATRA $13.64
- Average True Range (ATR)
- LVO 0.10
- ATRA 0.91
- MACD
- LVO -0.00
- ATRA -0.39
- Stochastic Oscillator
- LVO 46.24
- ATRA 3.28
About LVO LiveOne Inc.
LiveOne Inc, formerly LiveXLive Media Inc is a premium internet network devoted to live music and music-related video content. The company has been building an online destination for music fans to enjoy live performances from music venues and music festivals around the world, such as Rock in Rio, Outside Lands Music and Arts Festival, and Hangout Music Festival, as well as original content, artist exclusives, and industry interviews. The Company operates mainly through three segments, PodcastOne, Slacker, and Media Group, with a majority of its revenue derived from the Slacker segment.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).